Management tracks

Gene editing company Casebia Therapeutics (Cambridge, Mass.), a JV formed by Bayer AG (Xetra:BAYN) and CRISPR Therapeutics AG (NASDAQ:CRSP), named James Burns president and CEO. He was head of the North American R&D hub at Sanofi (Euronext:SAN; NYSE:SNY).

Biosimilars, complex generics and autoimmune company Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) named Scott Storer as SVP and CFO, replacing retiring CFO Rick Shea. Storer was SVP of finance at Baxalta Inc., which was acquired by Shire plc (LSE:SHP; NASDAQ:SHPG)...